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In Silico identification of a common 
mobile element insertion in exon 4 
of RP1
Dongju Won1,8, Joo‑Yeon Hwang2,3,8, Yeeun Shim4, Suk Ho Byeon4,5, Junwon Lee6, 
Christopher Seungkyu Lee5, Min Kim6, Hyun Taek Lim7, Jong Rak Choi1, Seung‑Tae Lee1* & 
Jinu Han6*
Mobile element insertions (MEIs) typically exceed the read lengths of short‑read sequencing 
technologies and are therefore frequently missed. Recently, a founder Alu insertion in exon 4 of RP1 
has been detected in Japanese patients with macular dystrophy by PCR and gel electrophoresis. 
We aimed to develop a grep search program for the detection of the Alu insertion in exon 4 of RP1 
using unprocessed short reads. Among 494 unrelated Korean patients with inherited eye diseases, 
273 patients with specific retinal phenotypes who were previously genotyped by targeted panel or 
whole exome sequencing were selected. Five probands had a single heterozygous truncating RP1 
variant, and one of their unaffected parents also carry this variant. To find a hidden genetic variant, 
whole genome sequencing was performed in two patients, and it revealed AluY c.4052_4053ins328/p.
(Tyr1352Alafs*9) insertion in RP1 exon 4. This AluY insertion was additionally identified in other 3 
families, which was confirmed by PCR and gel electrophoresis. We developed simplified grep search 
program to detect this AluY insertion in RP1 exon 4. The simple grep search revealed a median variant 
allele frequency of 0.282 (interquartile range, 0.232–0.383), with no false‑positive results using 120 
control samples. The MEI in RP1 exon 4 was a common founder mutation in Korean, occurring in 
1.8% of our cohort. The RP1‑Alu grep program efficiently detected the AluY insertion, without the 
preprocessing of raw data or complex installation processes.
Inherited retinal diseases (IRD) are genetic eye diseases with high  heterogeneity1. Next-generation sequenc-
ing (NGS) has improved the diagnostic rate of IRDs substantially. However, approximately 30–40% of patients 
do not achieve a definitive molecular diagnosis after whole-exome sequencing (WES) or even whole-genome 
sequencing (WGS)2,3. The disease-causing variants in these cases may be regulatory non-coding variants, deep 
intronic variants, mobile element insertions (MEIs), complex structural variants, or variants residing in repeti-
tive low-complexity sequences, which are difficult to map or are easily missed in annotations of non-canonical 
transcripts. Improvements in bioinformatics and exome re-analysis method can increase the diagnostic rate for 
previously undiagnosed retinal  diseases2.
Since the initial discovery of MEIs in corn by Barbara  McClintock4, their crucial roles have been implicated in 
human  diseases5,6. Several MEIs are associated with IRDs, such as retinitis pigmentosa (RP) or optic  atrophy7–11. 
“Jumping gene” insertions caused by retrotransposons, such as long interspersed element 1 or short interspersed 
nuclear elements, can disrupt genes, leading to Mendelian disorders. These MEIs typically exceed read lengths 
for short-read sequencing technologies. Therefore, special bioinformatic approaches for transposable element 
identification, such as MELT and Mobster, have been  developed12,13.
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As transposable elements in the human genome account for approximately 45% of the total DNA content, 
it is difficult to determine whether certain MEIs are pathogenic. Recently, a founder Alu (a short interspersed 
nuclear element) insertion in exon 4 of RP1 has been reported in Japanese patients with macular  dystrophy10,14,15, 
as determined by optimized polymerase chain reaction (PCR)-based amplification with gel electrophoresis or 
Sanger sequencing. The genetic relatedness of Korean and Japanese populations suggests that founder RP1-Alu 
insertions may also be found in Koreans with macular dystrophy or cone-rod dystrophy (CRD). However, PCR 
and gel electrophoresis are time- and labor-intensive methods. Therefore, we developed a simple approach for 
detecting Alu insertions in RP1 exon 4 from raw NGS data based on the known sequence of the mutant junction 
and applied the method to a Korean cohort with IRD with previously generated targeted panel NGS or WES data.
Results
At the time of the analysis, 233 patients with IRDs were sequenced and analyzed by WES (clinicaltrials.gov: 
NCT03613948) (Fig. 1), including 168 patients with Leber congenital amaurosis (LCA), CRD, Stargardt disease, 
macular dystrophy, and RP. We identified four unsolved cases with macular dystrophy or CRD carrying a sin-
gle heterozygous truncating mutation in RP1 (NM_006269.1) based on a WES analysis (Fig. 2 and Figure S1). 
However, autosomal dominant inheritance was unlikely because an unaffected parent also had this variant and 
the minor allele frequency (MAF) was high. Additionally, the variants were located in a region with autosomal 
recessive  inheritance16. Trio-based WGS of family D and proband-only WGS of one proband (family B) revealed 
no RP1 copy number variants or structural variants. The RP1 genomic region showed a more complex event 
leading to incorrect variant calling. A WGS analysis of one patient (family B) revealed the c.4052_4053insGGC 
CGG GCG CGG TGG CTC ACG CCT GTA ATC CCA GCA CTT TGG G: p.(Tyr1352Alafs*9) variant along with 
c.5797C > T:p.(R1933*), with a low variant allele frequency (VAF) (19.6%, allele depth = 41:10, REF:ALT) and 
VQSRTrancheINDEL 99.95–100.00. Genome Analysis Toolkit uses a machine learning model to differentiate 
true variants from false positives. A VQSRTrancheINDEL of ≥ 99.00 corresponds to tranches with more false 
positives. Therefore, VQSRTrancheINDEL 99.95–100.00 indicates a high probability of false positives. However, 
the soft clipped part of reads (i.e., the longest 122 bp) and opposite side of the poly-A tail in the WGS analysis 
of B.II-1 revealed an insertion of an AluY retrotransposon at chr8:55,540,494 (hg19) (Fig. 3A,B). WES or WGS 
analyses of the four probands (A–D) and the mother of unaffected patient D yielded similar results. Accordingly, 
we re-examined targeted NGS data for 105 patients with LCA, CRD, Stargardt disease, macular dystrophy, or 
RP (Fig. 1). We identified one additional patient (family E) with macular dystrophy previously thought to be 
unsolved because he harbored only one heterozygous nonsense c.5797C > T variant in RP1 (Fig. 2E). Likewise, 
abnormal reads with low VAFs were suspected between c.4052 and c.4053 in RP1, as determined using Integra-
tive Genomics Viewer, but no variants were called at the position.  
To better detect Alu insertions at this location in RP1 in patients with macular dystrophy or CRD, we designed 
a simple grep search program including the reference sequence (13 bp) and AluY sequence (13 bp) at the junction. 
We identified an Alu insertion in RP1 exon 4 in unsolved patients with the disease-causing variant p.(Arg1933*) 
in families B, C, and E, p.(Ile1528Valfs*10) in family A, and p.(Cys1399Leufs*5) in family D. Interestingly, macu-
lar dystrophy without peripheral retinal dystrophy was observed with c.5797C > T:p.(Arg1933*) and early-onset 
Figure 1.  Inherited eye disease cohort. A total of 494 unrelated patients with inherited eye diseases underwent 
targeted panel next-generation sequencing or whole-exome sequencing. A subset of samples with Leber 
congenital amaurosis, cone-rod dystrophy, Stargardt disease, macular dystrophy, or retinitis pigmentosa 
underwent an additional RP1-Alu analysis. Among 273 patients, 1.8% patients had the RP1-Alu insertion.
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CRD was observed with c.4582_4585del:p.(Ile1528Valfs*10) (family A.II-2) and c.4196del:p.(Cys1399Leufs*5) 
(family D.II-2). The latter two patients had childhood-onset nystagmus and were legally blind at the age of 
20 years (Table 1).
Alu insertions between c.4052 and c.4053 in RP1 were suspected for the five patients described above. We 
confirmed the Alu insertion in exon 4 of RP1 by PCR and gel electrophoresis using samples from four patients 
and their available parents (Figure S2); patient D was excluded owing to the lack of residual sample. An approxi-
mately 300-bp insertion was identified in the probands (family A–C and E); in the probands of families A and 
B, the insertion originated from the father and mother, respectively. The mother of the proband in family E had 
no RP1 insertion; thus, the insertion likely originated from the father. Sanger sequencing of RP1 of the parents 
in families A and B and WGS of the parents in family D revealed that the insertion and another truncating vari-
ant in RP1 in families A, B, and D were located in trans. Sanger sequencing revealed that RP1 c.5797C > T:p.
Figure 2.  (A–E) Pedigree and retinal images of patients carrying the RP1-Alu insertion. Patients B, C, and E 
with c.5797C > T:p.(Arg1933*) had macular dystrophy without peripheral retinal degeneration. However, rod 
involvement around the retinal vascular arcade showed c.4582_4585del:p.(Ile1528Valfs*10) and c.4196del:p.
(Cys1399Leufs*5).
Figure 3.  (A) Next-generation sequencing data from the Integrative Genomics Viewer at the Alu insertion 
junction from whole-genome sequencing of B.II-1 and one control sample. Integrative Genomics Viewer with 
“show soft-clipped bases” revealed multiple reads with aberrant alignments on the right side corresponding to 
an Alu Y insertion. (B) On the left side of aberrant soft-clipped bases from whole-genome sequences of D.I-2., 
Alu Y with the poly(A) tail was found. The space between the Alu insertion and poly(A) tail corresponds to 
target site duplication (sequence: AAA GAA AACAC). Coverage depth decreased sharply at the junction of the 
Alu insertion (red arrow).
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(Arg1933*) in the proband of family E originated from the mother, indirectly confirming that the variant and 
Alu insertion in the proband of family E were in trans. The Alu sequence was determined by Sanger sequencing 
of a purified ~ 672 bp band in gel electrophoresis. Except for the poly(A) tail, 5 of 282 bases in Alu differed from 
the previously reported Alu Y reference (Figure S3)17. Interestingly, some bases preceding the Alu insertion were 
detected behind the poly(A) of Alu Y in duplicate. These two direct repeats were likely introduced during the 
Alu insertion. The Alu sequence reported in the Japanese population has not been reported and thus it was not 
possible to confirm that the same element was present. However, the high prevalence in cases in both Korea and 
Japan and the identical position strongly suggest that the event was a common founder effect. The predictive 
pathogenicity and population frequency of the variants are summarized in Table S1.
Validation of the grep search. Using the bash grep command, we found a median VAF of 0.282 (inter-
quartile range, IQR, 0.231–0.383) in nine sets of sequencing data from six patients (five probands and the mother 
of proband D) for the heterozygous RP1-Alu insertion (Table S2). The median VAF was 0.229 in targeted panel 
sequencing data (n = 2), 0.261 (IQR, 0.201–0.333) in WES (n = 4), and 0.447 (IQR, 0.382–0.452) in WGS (n = 3) 
(Table S2). To validate the grep search method, we applied it to targeted panel sequencing (n = 20), WES (n = 80) 
and WGS (n = 20) samples with other diseases, such as FRMD7-related infantile nystagmus, congenital cataract, 
or inherited optic neuropathy. No mutant reads were detected in these control samples.
Comparison with other mobile element detection tools. We used the MELT, Mobster, and SCRAM-
ble tools to compare the efficacy and runtime for MEI detection in RP1 exon  412,13,18. The RP1-Alu was not called 
in two targeted NGS samples using the MELT algorithm and in one WES sample (Patient C.II-2) using the 
Mobster and SCRAMble algorithms (Table S3).
Computation time is a limiting factor when running MEIs detection tools using large datasets. For targeted 
panel data, the median runtimes were 101.5 s (IQR, 73–130 s) for MELT, 199 s (IQR, 142–256 s) for Mob-
ster, 92.5 s (IQR 50–135 s) in SCRAMble, and 49.5 s (IQR, 43–56 s) for the grep program. For WES data, the 
median runtimes were 240 s (IQR, 179–263.5 s) for MELT, 273 s (IQR, 256.5–312.5 s) for Mobster, 172.5 s (IQR, 
140–206.5 s) for SCRAMble, and 117.5 s (IQR, 100.5–126.5) for the grep program. For WGS data, the median 
runtimes were 91 min (IQR, 87.1–130.1 min) for MELT, 70.6 min (IQR, 64.4–84.1 min) for Mobster, 71.1 min 
(IQR, 69.7–95.2 min) for SCRAMble, and 29.0 min (IQR, 27.7–38.5 min) for the grep program (Fig. 4). The 
runtimes did not account for the pre-processing, filtering, and annotation of MEIs.
Discussion
RP1 is located on chromosome 8 and comprises 4 exons (3 coding) and 2156 amino acids. Most of reported 
disease-causing variants are clustered in the largest and terminal exon 4, and RP1 disease-causing variants show 
autosomal dominant or recessive inheritance patterns depending on the type and position of  variants16. We 
have found 5 unsolved cases with a single disease-causing variant in the RP1 region with autosomal recessive 
inheritance based on NGS data. The c.4052_4053ins328 Alu element insertion in RP1 seems to be the second 
variant in East Asian population.
Table 1.  Summary of demographic factors, visual acuity, and genetic data for the RP1-Alu insertion case 
series. BCVA best-corrected visual acuity, CF count finger, HM hand motion, NA not available, OD oculus 
dexter, OS oculus sinister, SE spherical equivalent.
Sample_name Sex Current Age (years)
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Several MEIs have been implicated in IRDs, including RP, choroideremia, or autosomal dominant optic 
 atrophy7,11,19,20. The AluYb8 insertion in MAK is a founder mutation in the Jewish  population8, and a BBS1 SVA 
F retrotransposon insertion is a frequent cause of Bardet-Biedl syndrome in  Europeans11. Furthermore, recent 
studies have identified MEIs as causative mutations in 0.04–0.15% of  cases18,21. The MAK-Alu grep program 
is an efficient tool for the detection of founder MEIs in the Jewish  population22,23. Studies aimed at detecting 
pathogenic MEIs in Asian populations are relatively limited, despite the potential for population-specific founder 
MEIs. Recently, a founder Alu insertion in exon 4 of RP1 has been reported with autosomal recessive inheritance 
in Japanese patients with macular  dystrophy10,14,15,24. Therefore, the founder MEI found in the Japanese popula-
tion should be also investigated in the Korean population.
MEIs can often be missed by NGS methods due to PCR amplification and targeted capture in both targeted 
panel and WES data. PCR and gel electrophoresis have been used to identify the Alu in exon 4 of RP1 in cases 
with a heterozygous, disease-causing variant in RP1 by targeted panel  sequencing15. However, this approach is 
time-consuming, expensive, and laborious. Therefore, we created a grep search program to detect the Alu in 
exon 4 of RP1 with previously generated raw NGS data, without requiring further experiments. By incorporating 
the simplified grep program in our clinical diagnostic pipeline, we detected MEI in RP1, which can provide a 
definitive molecular diagnosis that is typically missed by short-read sequencing. In our cohort with compatible 
phenotypes (n = 273), MEI was detected in 1.8% of patients, consistent with the frequencies reported in previ-
ous  studies24. Numa et al. suggested that tier-based approach is more efficient to detect pathogenic variants in 
Japanese RP as following orders: (1) Sanger sequencing of two major mutations in EYS, (2) targeted sequencing 
of all EYS coding exons, (3) WGS, and (4) Sanger sequencing of the Alu element in RP124. However, our grep 
program detected the RP1-Alu insertion efficiently without further experiments or sequencing and yielded no 
false-positives. Because this simple bash or R script does not require the preprocessing of raw data or a complex 
installation process, it can be easily integrated in any NGS pipeline for the analysis of East Asian patients with 
IRD.
RP1-Alu is absent from publicly available resources, such as the 2,504 controls in the 1,000 Genomes Project 
and 14,891 controls in gnomAD SV 2.1. However, the c.5797C > T:p.(Arg1933*) variant is relatively common in 
Korean and Japanese individuals. The MAF was 0.0060 in gnomAD Korean and 0.0021 in gnomAD East Asian. 
The MAF of c.5797C > T is also high (0.0076) in the Korean Reference Genome Database (1722 samples, http:// 
coda. nih. go. kr/ coda/ KRGDB/ index. jsp). This variant does not cause retinal dystrophy in either homozygous or 
heterozygous  individuals10. Interestingly, c.5797C > T with the Alu insertion causes macular dystrophy without 
peripheral retinal dystrophy.
However, the Alu insertion in trans with more proximal frameshift mutations (c.4196del or c.4582_4585del) 
causes childhood-onset nystagmus and severe macular dystrophy with rod involvement, consistent with early-
onset CRD. It occurs during childhood, with the first symptoms recognized in the first  decade25. When compared 
with that in LCA, visual function in early-onset CRD is slightly better, but progressive loss of retinal function 
leads to blindness in the second to third decade of life. We found that the RP1-Alu variant along with other 
frameshift mutations can cause childhood-onset retinal dystrophy with nystagmus, mimicking LCA or Stargardt 
Figure 4.  Runtimes of each tool for the detection of mobile element insertion. All tools were run using dual 
Xeon E5-2643V4 (12-core, 24 threads) and 64 GB of RAM.
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disease. As RP1 mutations cause CRD, RP, or macular dystrophy in either autosomal recessive or dominant states 
depending on the mutation location and  type26, careful evaluations of the family history and the locations of 
variants in RP1 are important, particularly when a single heterozygous disease-causing RP1 variant is found and 
the family history does not indicate autosomal dominant inheritance.
MEIs can be detected using the MELT or Mobster algorithm based on discordant read pairs and clipped 
reads in combination with consensus sequences of known mobile  elements12,13. Additionally, SCRAMble shows 
relatively high sensitivity for the detection of MEIs occurring within a targeted capture  region18. These tools 
show reduced sensitivity for target enrichment sequencing relative to PCR-free genome sequencing because 
discordant read pairs can exist outside of target regions. Indeed, RP1-Alu was not detected in two targeted NGS 
samples using the MELT algorithm and in one WES sample using both Mobster and SCRAMble. Furthermore, 
our grep has various practical advantages over other algorithms, including the reduced computational time, no 
need for complex installation processes or preprocessing steps.
Despite these advantages, it should be emphasized that our RP1-Alu grep program is only useful to detect 
the founder MEI in exon 4 of RP1. Although no common variants have been reported within 13 bp upstream 
of the Alu insertion in gnomAD v2.1.1, a rare variant was found in gnomAD v3.1 (hg38: 8–54,627,925-A-G: 
MAF = 1/152,184) 10 bp upstream of the Alu insertion site. To allow one mismatch within junction of the Alu 
insertion, R agrep program will yield positive results in such cases. We were also unable to confirm the validity 
of the method in patients with a homozygous RP1-Alu insertion or in other populations.
In conclusion, our results showed that the RP1-Alu insertion is common in Koreans with IRD, occurring in 
1.8% of patients with IRD. RP1-Alu grep detected this common MEIs with no false-positive results. These find-
ings provide a basis for further studies of the founder RP1-Alu insertion in pre-existing NGS data in East Asian 
patients with unsolved IRD. We also determined the full sequence of the inserted Alu Y. In unsolved early-onset 
CRD or macular dystrophy, RP1-Alu should be investigated using short-read sequencing data in East Asians.
Methods
Patient cohort and Alu detection process. The study protocol adhered to the tenets of the Declara-
tion of Helsinki and was approved by the Institutional Review Boards of Yonsei University College of Medicine, 
Gangnam Severance Hospital (3–2020-0330). All probands were unrelated. Patients with clinical information 
were recruited and clinically examined at Severance Hospital, Yonsei University College of Medicine. Informed 
consent was obtained from all subjects or, for subjects under 18  years of age, from a parent or legal guard-
ian; informed consent included consent for the publication of identifying information/images. Blood samples 
were collected for DNA extraction; 494 unrelated patients with inherited eye diseases, including FRMD7-related 
infantile nystagmus, congenital cataract, Stickler syndrome, familial exudative vitreoretinopathy, inherited optic 
atrophy, PR, LCA, CRD, and macular dystrophy, were identified. In total, 261 patients were evaluated by targeted 
panel NGS and 233 patients were evaluated by WES using xGen Exome Research Panel v1 (Integrated DNA 
Technologies, Coralville, IA, USA) and Twist Human Comprehensive Exome (Twist Bioscience, San Francisco, 
CA, USA). Proband-only WGS or trio WGS was additionally performed for 16 unresolved cases after targeted 
panel NGS or WES. Sequencing and bioinformatic analyses were performed as described previously and are 
summarized briefly in the Supplement  methods27,28. Probands with LCA, Stargardt disease, CRD, macular dys-
trophy, and RP were screened. We evaluated unsolved patients with only one disease-causing variant in RP1 for 
selected probands and implemented a newly developed grep search program with FASTQ files to detect the Alu 
insertion in exon 4 of RP1. We additionally tested the program using control samples. Suspected Alu insertions 
in RP1 were confirmed by PCR and electrophoresis.
Grep program to detect RP1‑Alu. The Linux grep command was used to search FASTQ files for the 5′ 
junction between the reference sequence of exon 4 and the beginning of the Alu insertion in RP1. Most FASTQ 
files without the insertion returned a count of "0," though in rare cases a false-positive read count of 1 or 2 was 
detected in wild-type samples depending on the coverage depth and sequencing method. The variant allele 
frequency (VAF) was calculated as mutant read count/(wildtype read count + mutant read count). The program 
returns “No AluY insertion: VAF < 0.1,” “AluY insertion suspected: 0.1 ≤ VAF < 0.3,” or “AluY insertion detected: 
VAF ≥ 0.3.” The grep search program is described in detail in the Supplementary methods.
The comparison of Mobile Element Insertion (MEI) detection callers. We compared efficacy and 
runtimes with MELT (v2.2.2, https:// melt. igs. umary land. edu/) 12, Mobster (v0.2.4.1, https:// github. com/ jyheh 
ir/ mobst er) 13, and SCRAMble (v1.0.1, https:// github. com/ GeneDx/ scram ble) 18, for NGS sequencing data from 
targeted panel sequencing (n = 2), WES (n = 4) and WGS (n = 3) samples. All tests were done with default set-
ting, and -exome TRUE parameter was used only for targeted panel sequencing and exome sequencing in MELT 
algorithm. The real wall clock time in time command was used to check the runtimes. All tools were run using 
dual Xeon E5-2643V4 (12-core, 24 threads) and 64 GB of RAM.
Data availability
Data supporting the findings of this manuscript are available from the corresponding author upon reasonable 
request.
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